Efficacy and Safety of Calculus Bovis Sativus in Adults With MAFLD

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

July 31, 2026

Conditions

Metabolic Dysfunction-associated Fatty Liver Disease

Interventions

DRUG

Calculus bovis sativus

Calculus bovis sativus 200mg qd

DRUG

Placebo

Placebo 200mg qd

Trial Locations (1)

Tongji Hospital, Tongji Medical College, HUST, Wuhan

All Listed Sponsors

lead

Huazhong University of Science and Technology

OTHER